| dc.contributor.author | Isikdogan, A | |
| dc.contributor.author | Turk, H | |
| dc.contributor.author | Bilir, C | |
| dc.contributor.author | Sendur, M | |
| dc.contributor.author | Karabulut, B | |
| dc.contributor.author | Artac, M | |
| dc.contributor.author | Cicin, I | |
| dc.contributor.author | Geredeli, C | |
| dc.contributor.author | Alacacioglu, A | |
| dc.contributor.author | Kefeli, U | |
| dc.contributor.author | Harputluoglu, H | |
| dc.contributor.author | Bozkurt, O | |
| dc.contributor.author | Cubukcu, E | |
| dc.contributor.author | Tural, D | |
| dc.contributor.author | Sakin, A | |
| dc.contributor.author | Cil, T | |
| dc.contributor.author | Dane, F | |
| dc.contributor.author | Cevik, D | |
| dc.contributor.author | Arslan, C | |
| dc.contributor.author | Karadurmus, N | |
| dc.contributor.author | Gumus, M | |
| dc.contributor.author | Yalcin, S | |
| dc.date.accessioned | 2023-01-02T08:53:08Z | |
| dc.date.available | 2023-01-02T08:53:08Z | |
| dc.date.issued | 2022 | |
| dc.identifier.uri | http://hdl.handle.net/11616/86956 | |
| dc.source | ANNALS OF ONCOLOGY | |
| dc.title | First-line anti-EGFR agents (panitumumab or cetuximab) plus chemotherapy | |
| dc.title | in patients with metastatic colorectal cancer: Onco-colon Turkey study | |
| dc.title | subgroup analysis |
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||